The management requirements are extremely high. Most regions or countries have classified health products into the food system, such as Canada, the United States, Japan, and the European Union. Only Australia took the lead in classifying health products into the drug system, and uniformly supervised health products according to the requirements of drug regulation.
管理要求极高。大部分地区或国家都将保健品划入食品体系中,如加拿大、美国、日本、欧盟,只有澳洲率先将保健品划入药品体系,按照药品监管的要求对保健品进行统一监管。
The scope of management is comprehensive. TGA is responsible for the evaluation of new drugs, formulation of standards, implementation of testing, issuance of drug manufacturing licenses, supervision of drug production processes, sampling of drug markets, inspection of drug manufacturers, inspection of drug production records, and handling complaints, so as to ensure that the "whole chain of life" of each health product is under the transparent supervision process of TGA.
管理范围全面。TGA对评估新药、制定标准、执行检测、颁发药品制造许可、监督药品生产过程、抽检药品市场、视察药品生产制造厂、检查药品生产记录以及处理投诉等流程,全部一管到底,保证每一个保健品的“生命全链条”都在TGA透明的监管流程之下。

Why Australia? 为什么选用澳洲产品？

The formula of repeated experiments. Australian health care products are basically made of animals, plants or minerals. Artificial ingredients cannot be added and the composition of the formula cannot be changed at will. And like drugs, the formula of health care products should be introduced to the market after repeated laboratory tests and tests, so as to maintain the safety and efficacy of the products to the greatest extent.
反复实验的配方。澳洲的保健品基本上是以动植物或矿物质作为原材料,不能随意添加人工成分和改变配方构成。而且和药品一样,保健品的配方要经过反复的实验室试验和检测之后才被推向市场,最大程度维持了产品的安全性和功效性。
Continuous market tracking. Unlike other institutions that only focus on the "one hammer deal" of early-stage approval, for health products registered in TGA and circulating in the market, TGA will regularly take samples from the market for stability tests to ensure that their quality does not deviate and remains in the best condition.
持续的市场跟踪。与其他机构只注重前期审批的“一锤子买卖”不同,对于在TGA注册并在市场流通的保健品,TGA会定期从市场中抽取样品进行稳定性测试,以确保其品质不出现偏差,依旧维持着最佳状态。